Question 2356 — health

Summary

Mr. Brahim Hammouche draws the attention of the Minister of Solidarity and Health to the situation of women who have suffered serious problems and injuries following the installation of Essure implants as part of definitive contraception. The German pharmaceutical laboratory Bayer Healthcare announced on September 18, 2017 that it was ending their marketing in France, following the suspension of its CE marking. However, he did not plan to removal protocol, which forces victims to individually undertake cumbersome administrative procedures to have these implants removed through a surgical operation. The lack of training of gynecological explant surgeons further complicates the procedures to be carried out. Also, he asks him to kindly inform him if it is envisaged on the one hand to establish a common national withdrawal protocol from the device to all gynecologists and also to entrust the centralized management of investigation files to the National Office for Compensation for Medical Accidents.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.